Skip to main content
. 2022 Jan 12;2022:2972275. doi: 10.1155/2022/2972275

Table 1.

Univariable analysis of AKI with cancer patients' background characteristics and comorbidities.

Variables Total frequency (%) AKI +ve frequency (%) AKI −ve frequency (%) P value
Gender
 Male 309 (48.4%) 21 (6.8%) 288 (93.2%) 0.923
 Female 329 (51.6%) 23 (7%) 306 (93%)
Age in years (mean ± SD) 54.7 ± 12.9 58 ± 7.5 54.5 ± 13.2 0.082∗∗
Diabetes
 Yes 135 (21.2%) 8 (5.9%) 127 (94.1%) 0.616
 No 503 (78.8%) 36 (7.2%) 467 (92.8%)
Hypertension
 Yes 97 (15.2%) 15 (15.5%) 82 (84.5%) <0.001
 No 541 (84.4%) 29 (5.4%) 512 (94.6%)
Ischemic heart disease
 Yes 34 (5.3%) 2 (5.9%) 32 (94.1%) 0.810
 No 604 (90.7%) 42 (7%) 562 (93%)
Obstructive lung disease
 Yes 11 (1.7%) 2 (18.2%) 9 (81.8%) 0.136
 No 627 (98.3%) 42 (6.7%) 585 (93.3%)
Benign prostatic hyperplasia
 Yes 9 (1.4%) 0 9 (100%) 0.411
 No 629 (98.6%) 44 (7%) 585 (93%)
Chronic kidney disease
 Yes 14 (2.2%) 6 (42.9%) 8 (57.1%) <.001
 No 624 (97.8%) 38 (6.1%) 586 (93.9%)
Hepatitis B
 Yes 9 (1.4%) 2 (22.2%) 7 (77.8%) .68
 No 629 (98.6%) 42 (6.7%) 587 (93.3%)
Distant metastasis
 Yes 414 (64.9%) 24 (5.8%) 390 (94.2%) .136
 No 224 (35.1%) 20 (8.9%) 204 (91.1%)
History of nephrectomy
 Yes 17 (2.7%) 4 (23.5%) 13 (76.5%) .006
 No 621 (97.3%) 40 (6.4%) 581 (93.6%)
Congestive heart failure
 Yes 4 (0.6%) 2 (50%) 2 (50%) .001
 No 634 (99.4%) 42 (6.6%) 592 (93.4%)
Multiple cancers
 Yes 12 (1.9%) 4 (33.3%) 8 (66.7%) <.001
 No 626 (98.1%) 40 (6.4%) 586 (93.6%)
Retroperitoneal disease
 Yes 29 (4.5%) 1 (3.4%) 28 (96.6%) .453
 No 609 (95.5%) 43 (7.1%) 566 (92.9%)

Chi-square test. ∗∗Independent t-test.